Skip to main content
Maria DeVita, MD, Nephrology, New York, NY

MariaVirginiaDeVitaMD

Nephrology New York, NY

Professor of Medicine, Zucker Hofstra/Northwell School of Medicine

Dr. DeVita is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. DeVita's full profile

Already have an account?

  • Office

    130 East 77th Street
    5th Floor
    New York, NY 10075
    Phone+1 212-434-6800
    Fax+1 212-734-2133

Education & Training

  • Zucker School of Medicine at Hofstra/Northwell at Lenox Hill Hospital
    Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalFellowship, Nephrology, 1987 - 1989
  • Zucker School of Medicine at Hofstra/Northwell at Lenox Hill Hospital
    Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalResidency, Internal Medicine, 1984 - 1987
  • Georgetown University School of Medicine
    Georgetown University School of MedicineClass of 1984

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 1989 - 2025
  • NY State Medical License
    NY State Medical License 1985 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

  • New York Magazine: Top Doctors Castle Connolly, 2014
  • Top Doctors: New York Metro Area Castle Connolly, 2009-2014
  • Top MD Consumers Checkbook
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Nuwellis Announces Data Demonstrating Statistically Superior Clinical Benefit of Aquadex Therapy in Reducing Heart Failure Events and Mortality at the 2022 HFSA Meeting
    Nuwellis Announces Data Demonstrating Statistically Superior Clinical Benefit of Aquadex Therapy in Reducing Heart Failure Events and Mortality at the 2022 HFSA MeetingOctober 3rd, 2022
  • Nuwellis Announces the Activation of New Sites for Its Pivotal REVERSE-HF Trial
    Nuwellis Announces the Activation of New Sites for Its Pivotal REVERSE-HF TrialSeptember 27th, 2022
  • Nuwellis Announces First Patient Enrolled in Its Pivotal Trial REVERSE-HF
    Nuwellis Announces First Patient Enrolled in Its Pivotal Trial REVERSE-HFJune 29th, 2022
  • Join now to see all

Professional Memberships